Director IPA Growth at Akido Labs | Chino, CA | $140K/yr – $160K/yr

Akido Labs

Director IPA Growth

Chino, CA (On-site)

$140K/yr – $160K/yrDirector/Executive7+ years expFull time

Posted 7 weeks ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own network growth for SoCal Medicare Advantage by expanding broker relations, building community referral pipelines, and recruiting providers, while turning Stars/HEDIS data into broker and community value.

Own growth pipeline and enrollment forecasts across MSO/IPA channels with payer ops and operations alignment.
Translate quality metrics into broker-facing stories to drive enrollment and community support.
Lead broker events, community outreach, and market intelligence to hit monthly growth targets.

Job Description

Responsibilities

Manage and grow a portfolio of broker and FMO relationships, serving as their primary point of contact for enrollment support, education, and co-marketing
Coordinate with health plan partner liaisons (SCAN, Alignment, etc.) on growth initiatives, directory accuracy, and IPA visibility
Identify and onboard net-new broker relationships with demonstrated Medicare Advantage book of business in target geographies
Build and maintain community referral pipelines through senior centers, CBOs, faith organizations, pharmacies, and ancillary providers
Own and update the growth dashboard — tracking membership trends, broker attribution, geo-penetration, and churn on a regular cadence
Surface provider-side issues identified through broker and plan relationships and facilitate resolution through MSO operational and clinical teams
Identify and recruit prospective providers to join the network, coordinating with operations to support onboarding and credentialing
Represent Akido at broker events, community health fairs, enrollment events, and culturally-targeted outreach programs across SoCal
Collaborate with quality and clinical teams to translate Stars and HEDIS performance into broker- and community-facing value narratives
Support payer contracting leadership with market intelligence, competitive analysis, and enrollment projections

Requirements

7+ years in healthcare business development, IPA/MSO growth, health plan sales, or broker relations (preferred)
3+ years in a director or senior manager capacity (preferred)
Deep familiarity with the Southern California Medicare Advantage landscape (preferred)
Established relationships with SoCal brokers, FMOs, or health plan partner teams (preferred)
Fluency in MA mechanics — product structures, broker compensation, CMS enrollment rules, and network adequacy standards (preferred)
Proven track record building and managing a business development pipeline with measurable enrollment outcomes
Ability to build and own growth pipeline models and enrollment forecasts
Comfortable working across MSO, medical group, finance, and payer contracting teams
Experience with CRM tools, enrollment reporting, or health plan portals
Executive-level communicator — effective in broker offices, community settings, and board rooms

Benefits

Health benefits include medical, dental and vision
401K
Long-term disability
Unlimited PTO
Life insurance
Paid Leave Program

Akido Labs

4.3 Glassdoor

We are pioneering a reimagined healthcare system; one that bridges technology and empathy to make exceptional healthcare a basic human right. For the first time in history, technology exists to create a healthcare system that anticipates your needs, responds with precision and is always accessible to all, regardless of financial means or geography. This has been our mission since day one. We were founded in 2015 by leaders in technology, social enterprise and hospital administration. Our team is made up of some of the brightest minds in artificial intelligence, healthcare, medicine and engineering, committed to ushering in a new era in care.

Founded in 2015

Los Angeles, California, USA

115 employees (8 in marketing)

www.akidolabs.com

88% recommend to a friend

86% CEO approval